ARL6IP1의 유전성 강직성 하반신마비의 치료 용도

Cited 0 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.author김남순-
dc.contributor.author이재란-
dc.contributor.author정초록-
dc.contributor.author정경숙-
dc.contributor.author임정화-
dc.contributor.author조현수-
dc.contributor.author김대수-
dc.date.accessioned2019-05-13T08:07:06Z-
dc.date.available2019-05-13T08:07:06Z-
dc.date.issued2019-10-30-
dc.identifier.other16250KR-1-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/18646-
dc.description.abstract본 발명은 ARL6IP1(ADP ribosylation factor like GTPase 6 interacting protein 1)의 단백질 또는 이를 코딩하는 유전자를 유효성분으로 포함하는, 유전성 강직성 하반신마비(Hereditary Spastic Paraplegia, HSP)의 치료용 약학적 조성물 및 상기 유전자의 발현수준 측정을 통한 유전성 강직성 하반신마비의 치료제 스크리닝 방법을 제공한다.-
dc.publisher한국생명공학연구원ko
dc.relation.haspart1511ko
dc.titleARL6IP1의 유전성 강직성 하반신마비의 치료 용도-
dc.title.alternativeUse of ARL6IP1 for treatment of Hereditary Spastic Paraplegia-
dc.typePatent-
dc.date.registration2019-10-30-
dc.contributor.affiliatedAuthor김남순-
dc.contributor.affiliatedAuthor이재란-
dc.contributor.affiliatedAuthor정초록-
dc.contributor.affiliatedAuthor정경숙-
dc.contributor.affiliatedAuthor임정화-
dc.contributor.affiliatedAuthor조현수-
dc.contributor.affiliatedAuthor김대수-
dc.date.application2017-08-25-
dc.identifier.patentApplicationNumber10-2017-0108108-
dc.identifier.patentRegistrationNumber10-2040893-
dc.publisher.location대한민국-
dc.contributor.assignee한국생명공학연구원-
dc.contributor.inventor임정화-
dc.description.patentCountryDivision국내-
Appears in Collections:
Division of Biomedical Research > Rare Disease Research Center > 2. Patents
Division of Research on National Challenges > Stem Cell Convergenece Research Center > 2. Patents
Division of Research on National Challenges > 2. Patents
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.